Evaluate the Value of Telehomecare for Diabetes
Launched by WOMEN'S COLLEGE HOSPITAL · Jun 21, 2016
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
Background
BlueStar is a smart-phone enabled application that is designed to serve as a virtual coach for patients. The app sends daily evidence-based, real-time messages as well as longitudinal feedback on how to improve diabetes management. Benefits have been demonstrated in time periods as brief as three months. One US based study showed a decrease in hospitalizations and emergency department visits among participants who use the application. The BlueStar application is the first application in the USA to be given FDA approval as a Mobile Prescription Therapy. There is a need to explore...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults, 18 years or older, currently being treated for Type II diabetes
- • 2. HgbA1C greater or equal to 8.0% and at least 1.0% above target within the last 3 months
- • 3. Have a functional email address or be willing to obtain one
- • 4. Be functional in reading the English language (self reported)
- Exclusion Criteria:
- • 1. Have Type I diabetes or Latent autoimmune diabetes of adults (LADA)
- • 2. Are on continuous glucose monitoring
- • 3. Have an insulin pump
- • 4. Are on dialysis
- • 5. Are pregnant.
- • 6. Are unable to use a computer or mobile phone due to severe mental or physical impairment
About Women's College Hospital
Women's College Hospital (WCH) is a leading academic health sciences center in Toronto, dedicated to advancing women's health through innovative research, education, and exceptional patient care. As a progressive institution, WCH focuses on addressing the unique health needs of women, fostering groundbreaking clinical trials that contribute to the understanding and treatment of various health conditions. With a commitment to collaboration, WCH partners with various stakeholders, including academic institutions and healthcare organizations, to enhance the quality of care and improve health outcomes for women. Through its robust research programs, Women's College Hospital is at the forefront of shaping future healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Sacha Bhatia, MD, FRCP(C)
Principal Investigator
Women's College Hospital Institute for Health Systems Solutions and Virtual Care (WIHV)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials